backWASHINGTON, D.C., June 20, 2023 — Law360 has selected King & Spalding partner Eva Temkin to serve on its 2023 Life Sciences Editorial Advisory Board. Law360 editors rely on the board members for insight into the latest issues affecting various practice areas and feedback on how the publication can improve its coverage.
Temkin provides strategic counsel to clients regarding significant and complex issues associated with FDA-regulated biomedical products. She draws upon her experience with these products at the FDA to help clients navigate development, approval, post-market regulation and life-cycle management of drugs and biologics, biosimilars, and combination products.